This inventor holds 7 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Phyton Holdings, LLC, Dfb Biotech, Inc., The Dow Chemical Company. Active years: 2006-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 15 
1 out of 1 
1 out of 7,680 
Years Active: 2006-2017
Title: Innovator in Glycoprotein Production - Kazuhito Fujiyama
Introduction
Kazuhito Fujiyama is a prominent inventor based in Osaka, Japan, known for his significant contributions to the field of glycoprotein research. With seven patents to his name, Fujiyama's work primarily focuses on innovative methods for the production and modification of glycoproteins in plant cells, enhancing their functionality for various applications.
Latest Patents
Fujiyama’s latest patents include groundbreaking methodologies for the co-expression of galactosyltransferase and glycoproteins within transgenic plant cells. One notable patent is centered on a method that facilitates the secretory production of glycoproteins with human-type sugar chains. This process involves several steps, starting with the introduction of specific enzyme genes to transform plant cells, followed by culturing and recovering the glycoproteins from the plant's culture medium. Another significant invention details the procedure for isolating these glycoproteins and sialylating them through the addition of sialic acid residues, ensuring they possess the desired human-type glycan structures.
Career Highlights
Kazuhito Fujiyama has worked with several influential organizations, including Phyton Holdings and DFB Biotech. Through his roles in these companies, he has advanced research in biotechnology and contributed to important scientific developments that may have lasting impacts in fields such as medicine and agriculture.
Collaborations
Fujiyama has collaborated with esteemed colleagues, including Tatsuji Seki and Toshiomi Yoshida. These partnerships have played a crucial role in enhancing the scope and depth of his research, allowing for innovative approaches to glycoprotein construction and production.
Conclusion
Kazuhito Fujiyama stands out as a key figure in biotechnological innovations, especially in the area of glycoprotein production. His pioneering patents reflect his dedication to advancing the industry and highlight his significant contributions alongside respected coworkers. As research in this domain continues to evolve, Fujiyama's work is likely to influence future advancements in biomedicine and related fields.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile